The big one here is eliminating the DEA ban on e-prescribing for controlled substances. Many physicians who currently e-prescribe have complained about this being one big drawback for the entire process, and rightly so. As difficult as it has been to get new physicians to “buy in”, the DEA process only further complicates matters with implementation on a larger scale. As always, there’s a link on the blog to the free NEPSI e-Prescribing program in the right hand column. BD
Two new reports stress the benefits of electronic prescribing and the need to accelerate physician adoption of the technology.
The report examines such obstacles to e-prescribing as financial burdens, workflow changes, connectivity issues and the need for better medication histories. Recommendations include replicating and expanding successful incentive programs, eliminating the Drug Enforcement Administration’s ban on e-prescribing for controlled substances, and creating a public-private e-prescribing advisory board. The report is available at ehealthinitiative.org.